**Abstract**

Endogenous opioid systems are involved in stress response and emotion regulatory processes. Stressful events release endogenous opioids and activate three different types of opioid receptors. Among these, μ type opioid receptors (mOR) are G-protein coupled receptors and regulate presynaptic neurotransmitter release probability. mOR deficient mice exhibit reduced anxiety, reduced depressive-like behaviors and decreased corcisoterone responses. However, whether this is due to the compensatory effect of constitutive genetic deficiency of mOR remains to be determined. The lateral habenula (LHb), a brain area involved in depressive disorders show the highest expression of mORs, however mOR in the LHb has not been investigated. To investigate the role of mOR in the LHb, we performed a whole-cell patch clamp recordings. We found that pharmacological mOR activation successfully decreases both excitatory and inhibitory neurotransmission in the LHb, while the net effect of mOR activation was reduction in synaptic transmission. Previous studies observed enhanced activity of the LHb in animal models of depression, thus reducing the activity of the LHb may contribute to reverse helpless behaviors. Surprisingly, mOR-induced decrease in synaptic transmission remains intact in the LHb obtained after exposure to an hour-long restraint plus tail-shock stress, raising the possibility of mOR activation as a pharmacological tool to reduce the activity of abnormally potentiated LHb after stress exposure. The selective activation of mOR in the LHb indeed ameliorate helpless behaviors after stress exposure. Our observation is consistent with clinical reports of the interaction between mOR and depression. Therefore, we suggest that the selective activation of mORs in the LHb may serve as a possible therapeutic strategy for treating depressive disorders.
